InvestorsHub Logo
Post# of 14878
Next 10
Followers 492
Posts 62722
Boards Moderated 0
Alias Born 08/28/2010

Re: None

Wednesday, 08/21/2019 3:30:33 PM

Wednesday, August 21, 2019 3:30:33 PM

Post# of 14878
$RBII ~ Allied Market Research, the global topical pain relief market is projected to reach $13.28 billion by 2025 at a CAGR of 7.4% from 2018 to 2025. This is huge for Rising Biosciences!

About Rising Biosciences, Inc.

About Rising Biosciences Inc.
- RBII operates three distinct business units. The first business unit is a physicians’ practice management company focused on the proper use of cannabis for the treatment of chronic pain, opioid addiction, and terminal patients. The second business unit is a research and development company focusing on oral and topical pharmaceuticals within the strict standards set forward by the pharmaceutical compounding industry and the FDA. The third business unit offers cutting edge behavioral health medical treatment for substance addiction from branches throughout the Midwest.

https://www.risingbiosciences.org/
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.